Our research using human embryonic stem cell (hESC)-based models revealed that inhibiting NOTCH signaling and reducing RB protein levels can lead to the development of PNECs, which may give rise to small cell lung cancer (SCLC) (Chen et al., 2019). Here, RB1 is linked to small cell lung carcinoma.